🩸 HematologySingle IV infusion (gene therapy)
HEMGENIX
Etranacogene Dezaparvovec
HEMGENIX is a gene therapy for adults with hemophilia B that delivers a functional copy of the Factor IX gene to reduce or eliminate bleeding episodes.
Form
Single IV infusion (gene therapy)
Uses
2
Side effects
4
Category
Hematology
01
What is HEMGENIX used for?
- Hemophilia B (Factor IX deficiency) in adults
- Prevention of uncontrolled bleeding in severe or moderately severe hemophilia B
02
Etranacogene Dezaparvovec side effects
Common side effects of Etranacogene Dezaparvovec include:
Elevated liver enzymes
Infusion-related reactions
Fatigue
Headache
CommonModerateLess common
03
Etranacogene Dezaparvovec warnings & precautions
- Risk of immune-mediated hepatotoxicity; monitor liver function tests
- Long-term safety and durability of response still being established
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand HEMGENIX in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.